Eric J Yang

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2020
Publications (10 Years): 8

Top Topics

Clinical Evaluation

Replacement Therapy

Atopic Dermatitis

Top Venues

Dermatologic therapy

American journal of clinical dermatology

Expert review of clinical pharmacology

Clinical, cosmetic and investigational dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Eric J Yang, Shari R Lipner
Differences in price trends between branded and generic medications for onychomycosis. Dermatologic therapy 33 (6) (2020)
Vidhatha Reddy, Bridget Myers, Eric J Yang, Tina Bhutani
Impact of Halobetasol Propionate and Tazarotene Lotion 0.01%/0.045% in the Management of Plaque Psoriasis in Adults. Clinical, cosmetic and investigational dermatology 13 (2020)
Vidhatha Reddy, Eric J Yang, Bridget Myers, Wilson Liao
Clinical Evaluation of Risankizumab-rzaa in the Treatment of Plaque Psoriasis. Journal of inflammation research 13 (2020)
Eric J Yang, Kristen M Beck, Wilson Liao
Tildrakizumab-asmn: What's in a Name? American journal of clinical dermatology 19 (3) (2019)
Eric J Yang, Kristen M Beck, Sahil Sekhon, Tina Bhutani, John Koo
The impact of pediatric atopic dermatitis on families: A review. Pediatric dermatology 36 (1) (2018)
Eric J Yang, Kristen M Beck, Melody Maarouf, Vivian Y Shi
Truths and myths in sunscreen labeling. Journal of cosmetic dermatology 17 (6) (2018)
Eric J Yang, Isabelle M Sanchez, Kristen Beck, Sahil Sekhon, Jashin J Wu, Tina Bhutani
Guselkumab for the treatment of moderate-to-severe plaque psoriasis. Expert review of clinical pharmacology 11 (4) (2018)
Eric J Yang, Kristen M Beck, Tina Bhutani, Steven Richard Feldman, Vivian Y Shi
Pharmacy costs of systemic medications for hidradenitis suppurativa in the United States. The Journal of dermatological treatment 30 (5) (2018)